↓ Skip to main content

Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study

Overview of attention for article published in Frontiers in Pharmacology, December 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study
Published in
Frontiers in Pharmacology, December 2022
DOI 10.3389/fphar.2022.1032995
Pubmed ID
Authors

Jaouad Azzahhafi, Thomas O. Bergmeijer, Wout W. A. van den Broek, Dean R. P. P. Chan Pin Yin, Senna Rayhi, Joyce Peper, Willem L. Bor, Daniel M. F. Claassens, Ron H. N. van Schaik, Jurriën M. ten Berg

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Librarian 4 33%
Researcher 2 17%
Student > Postgraduate 1 8%
Unknown 5 42%
Readers by discipline Count As %
Agricultural and Biological Sciences 4 33%
Medicine and Dentistry 2 17%
Unknown 6 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2022.
All research outputs
#20,680,602
of 23,275,636 outputs
Outputs from Frontiers in Pharmacology
#10,477
of 16,698 outputs
Outputs of similar age
#345,437
of 437,531 outputs
Outputs of similar age from Frontiers in Pharmacology
#564
of 1,076 outputs
Altmetric has tracked 23,275,636 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,698 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,531 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,076 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.